You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 32 C-reactive protein (CRP) as a prognostic biomarker in advanced non-small cell lung cancer treated with immune checkpoint inhibitors. Results from a multi-center international observational study

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Biomarkers, immune monitoring, and novel technologies
32 C-reactive protein (CRP) as a prognostic biomarker in advanced non-small cell lung cancer treated with immune checkpoint inhibitors. Results from a multi-center international observational study

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020196017
Dec 20203009
Jan 2021801
Feb 20212104
Mar 20213206
Apr 20212004
May 2021806
Jun 2021004
Jul 2021006
Aug 2021002
Sep 2021005
Oct 202120020
Nov 202136013
Dec 20211403
Jan 20221002
Feb 20221001
Mar 20221200
Apr 20223402
May 20223701
Jun 20221801
Jul 20223202
Aug 20226602
Sep 20229002
Oct 202210603
Nov 20228201
Dec 20226801
Jan 20235801
Feb 20238402
Mar 20234201
Apr 20235003
May 20235001
Jun 20234600
Jul 20236602
Aug 20233600
Sep 20232000
Oct 20235202
Nov 20234201
Dec 20239601
Jan 20242600
Feb 20248002
Mar 202416201
Apr 20247204
May 20244600
Jun 20244600
Jul 20245401
Aug 20243003
Sep 20246402
Oct 20243603
Nov 20243203
Dec 20242603
Jan 20252603
Feb 20251001
Mar 2025004
Apr 2025004
May 2025004
Jun 2025002
Total23020172